Fred E. Cohen

Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026

Time on boards

Boards served
5
Current seats
5
Board service
17 years
Director since
2023

17 years of board service in total across 5 boards, counting each seat separately. Longest: CareDx Inc., 3 years.

CareDx Inc. Director
3 years · Since 2023
Progyny Inc. Director
3 years · Since 2023
3 years · Since 2023
3 years · Since 2023
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 3, 2026 CareDx Inc. Gift −25,000 — —
Jun 12, 2026 CareDx Inc. Grant or award +9,795 — —
Jun 9, 2026 Intellia Therapeutics Inc. Grant or award +9,200 — —
May 27, 2026 Kyverna Therapeutics Inc. Grant or award +5,093 — —
Jan 5, 2026 Intellia Therapeutics Inc. Open-market purchase +150,000 $9.35 $1,402,500
Jun 13, 2025 CareDx Inc. Grant or award +12,103 — —
Jun 11, 2025 Intellia Therapeutics Inc. Grant or award +8,000 — —
May 29, 2025 Kyverna Therapeutics Inc. Grant or award +16,634 — —
Jun 14, 2024 CareDx Inc. Grant or award +10,570 — —
Jun 12, 2024 Intellia Therapeutics Inc. Grant or award +7,737 — —
May 23, 2024 Progyny Inc. Grant or award +6,176 — —
Feb 12, 2024 Kyverna Therapeutics Inc. Derivative conversion +4,523,924 — —
Jul 26, 2023 UroGen Pharma Ltd. Grant or award +69,339 $9.54 $661,494
Jun 16, 2023 CareDx Inc. Grant or award +18,844 — —
Jun 14, 2023 Intellia Therapeutics Inc. Grant or award +4,425 — —

Questions about Fred E. Cohen

What boards is Fred E. Cohen on?

Fred E. Cohen sits on the boards of CareDx Inc., Intellia Therapeutics Inc., Kyverna Therapeutics Inc., Progyny Inc. and UroGen Pharma Ltd.

How long has Fred E. Cohen served on boards?

Our records show at least 17 years of board service across 5 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.